Gene therapy for treating hemophilia A
Abstract:
Compositions and regimens useful in treating hemophilia A are provided. The compositions include recombinant adeno-associated virus (rAAV) with a transthyretin enhancer and promoter driving expression of a human Factor VIII.
Public/Granted literature
Information query
Patent Agency Ranking
0/0